PCRS support initiatives to improve air quality and minimise short- and long-term damage to the environment, particularly those with an impact on climate change resulting from greenhouse gases.
Conference Proceedings Highlights Abstracts Conference Feedback Plenary Session Highlights
PCRS offer two posters available for download and use in practice surgeries and pharmacies. The posters highlight the benefit of regular preventer inhaler therapy and a reduction in reliance on short -acting reliever inhalers. Both posters recommend talking to the practice nurse or ph
In this article, updated for asthma in November 2019, we discuss the building blocks of a good asthma review focusing on:
Case Study 1 - Noel Baxter Locum GP and PCRS Policy Lead discusses the importance of system change in the practice particularly around the reviewing and re-authorising of repeat prescriptions for short acting beta-2-agonsts
The playing cards on these slides and downloadable PDF playing cards are a way to trigger conversations with healthcare teams, and between pharmacists and patients regarding the use of/reliance on SABA inhalers. We invite you to use them to start a discussion!
In this article for Primary Care Respiratory Academy, Noel Baxter describes the nine good care processes developed by a multidisciplinary and integrated respiratory team in Lambeth and Southwark with a novel way to disseminate the measures and show improvement.
Patients with respiratory symptoms and disease deserve a correct diagnosis and correct guideline driven care that is standardized, patient focused, delivered by a Health Care Professional (HCP) with suitable training and experience, at a site and within an appropriate timeframe to meet their need
The least cost-effective inhaler device is the one that the patient cannot use. In deciding which device and drug formulation to prescribe healthcare professionals should first determine the patient’s ability to use the prescribed device correctly.
Fran Robinson talks to a patient who has had asthma all her life, feels that annual asthma reviews are a waste of time (except when they are conducted by PCRS members).
Key facts
PCRS welcome this further update of the long established, comprehensive and highly respected BTS/SIGN guideline for asthma.
Alongside a detailed clinical history and other important tests to assess variability (peak flow, reversibility and challenge tests) it is used to support the diagnosis of asthma. PCRS has produced this consensus position on the use of FeNO in primary care to support the diagnosis of as
We have guidelines on asthma from two different sources in the UK – BTS/SIGN and NICE. The British Asthma guideline from BTS/SIGN was first published in 2003 and is well established, respected and comprehensive.
Briefing document for National Respiratory Strategies – the NHS Long term plan and Lung Health Taskforce 5 year plan.